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Abstract
Two cases ofneonatal haemochromatosis,
a rare and often fatal metabolic disorder,
presenting with acute liver failure, are
reported. Both presented in the first week
of life with hypoglycaemia, jaundice, and
coagulopathy, with rapid deterioration of
liver function. Both received a transplan-
tation using reduced liver grafts. One
child was well 18 months later.
Few survivors have been reported and
despite the difficult perioperative man-
agement, liver transplantation is the best
treatnent for neonatal haemochromato-
sis.
(Arch Dis Child 1995; 73: F178-F180)
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Neonatal haemochromatosis is a rare and
frequently fatal disorder which causes either
death in utero or acute liver failure in the
neonate. The pathogenesis is uncertain: there
may be more than one cause. It has been
observed in siblings and in these cases seems to
be inherited as an autosomal recessive gene.' 2
No infectious aetiology has been identified.
Histologically, the condition is characterised
by intense deposition of stainable iron in the
liver, hepatocellular necrosis, and diffuse
hepatic fibrosis with nodular regeneration.
Other organs affected include the pancreas,
heart, thyroid and salivary glands, with a
characteristic sparing of the reticuloendothelial
system. About 60 cases have been reported,
with sporadic survivors described following
supportive treatment. Liver transplantation is a
definitive treatment but few successful cases
have been reported.34 We report two cases
born to parents with no consanguinity or
familial history of death in early infancy.
Case reports
CASE 1
A full term baby girl weighing 2-32 kg at birth
had an Apgar score of 9 at 5 minutes and
became hypoglycaemic within the first 48
hours of delivery with a blood glucose of
0-8 pumoVl. During the first week of life she
developed seizures related to hypoglycaemia,
jaundice, rectal bleeding, haematuria and
ascites. Despite a normal serum aspartate
transaminase (AST), the total serum bilirubin
was 320 mmol/l, alkaline phosphatase 1140
IU/1, albumin 24 g/l and the International
Normalised Ratio (INR) 5-6.
In both cases hepatitis A, B, and C, cyto-
megalovirus (CMV) Coxsackie virus, Epstein
Barr virus (EBV), echo 11-, adeno-, herpes
and parvoviruses were excluded by specific
serological and virological methods. The
following biochemical and metabolic disorders
were excluded: a 1 antitrypsin deficiency,
galactosaemia, tyrosinaemia, fatty acid oxida-
tion defects and bile acid disorders. Haemo-
phagocytic syndrome was excluded after a
bone marrow aspirate.
Serum iron was 31-3 mg/dl (range 10-30
mg/dl). The liver function continued to deteri-
orate and she received a transplantation at 5
weeks of age, receiving a reduced graft (left
lobe) from an 8-5 kg donor matched for blood
group.
The artery was reconstructed with a donor
iliac conduit and biliary drainage was
established with a Roux-en-Y hepatico-
jejunostomy. The first day after surgery her
INR gradually rose to 5 and an abdominal
Doppler ultrasound scan showed a blocked
portal vein. She was managed conservatively
and developed abdominal distension, ascites,
and sepsis and died three weeks after trans-
plantation.
Histopathological features of the explanted
livers were typical of neonatal haemochroma-
tosis in both cases, with hepatitis with giant cell
transformation and massive parenchymal
siderosis (figure). Postmortem findings
showed substantial haemosiderin deposition in
the pancreas.
CASE 2
A girl born at 40 weeks and weighing 3-46 kg
had an Apgar score of 9 at 1 and 5 minutes.
She developed asymptomatic hypoglycaemia
on day 2 and was admitted on day 9 because
of lethargy, jaundice, and poor feeding.
Laboratory findings (AST 74 IU/1, serum
bilirubin 453 ,umol/l, and INR 2 3) were con-
sistent with poor liver function. Further
investigation revealed a patent ductus arterio-
sus with a left to right shunt on Doppler ultra-
sonography. Despite supportive treatment her
liver function progressively deteriorated with
an INR of 4* 5 and she developed renal failure.
She became increasingly jaundiced, hypogly-
caemic, and acidotic, required ventilatory
support and was referred to our centre. She
received a transplantation on the 15th day of
life with a reduced graft (segments II and III)
from a 17 kg donor with a donor iliac conduit
and Roux loop for arterial and biliary
reconstruction, respectively. Ligation of the
patent ductus arteriosus was undertaken
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Liver histology of case 2: massive parenchymal iron deposition and giant cell
transformation.
immediately before transplantation. The
operative blood loss was 580 ml. Immuno-
suppressive treatment included prednisolone,
azathioprine, and cyclosporin. The acute
renal failure began to resolve 36 hours later,
but she was ventilated for 26 days after trans-
plantation. Other complications included
CMV infection treated with gancyclovir and
two episodes of gastrointestinal bleeding, for
which no cause could be found. She was dis-
charged 42 days after surgery and remained
well with normal liver function at the time
of writing. There was no evidence of iron
deposition in a liver biopsy specimen at 18
month follow up.
The measured iron concentration in the
hepatic tissue was significantly increased at
7631 mg/g dry weight (normal value <2000
mg/g dry weight).
Discussion
Neonatal haemochromatosis is a distinct clini-
copathological entity characterised by severe
hepatic insufficiency, with onset during
intrauterine life, in association with hepatic
and extrahepatic siderosis. Neonatal haemo-
chromatosis may present in pregnancy as
oligo- or polyhydramnios, placental oedema,
stillbirth, prematurity and growth retardation.
In affected neonates it invariably produces
acute liver failure within 20 days of life.
Neonatal haemochromatosis is unrelated to,
and has a different pathogenesis from, adult
haemochromatosis, although both have a
similar pattern of iron deposition. Hereditary
haemochromatosis is an autosomal recessive
inherited disease and the iron overload is
caused by excessive absorption from the gut.
Intestinal absorption of iron is normal in
neonatal haemochromatosis and the defect is
believed to be in the placenta, although no
affected placentas have been available for
examination. Regulation of transferrin and
ferritin in fibroblasts and the transferrin recep-
tor and ferritin genes seem to be normal.5 It
has been suggested that some cases of neonatal
haemochromatosis occur after hepatic injury in
utero rather than because of excessive trans-
port of iron from mother to fetus and that, in
some instances, an infective agent may be
responsible.6
Diagnosis of neonatal haemochromatosis is
usually made at necropsy on the basis of the
characteristic pattern of iron deposition in the
liver and other parenchymal organs, sparing
the reticulo-endothelial system. In neonates
presenting with acute liver failure underlying
viral and metabolic causes must be excluded,
particularly haemophagocytosis. The diag-
nosis of neonatal haemochromatosis is usually
made postoperatively and the criteria for
transplantation are those used for children
with fulminant hepatic failure.7 Iron studies
may support the diagnosis but are non-specific
and may be misleading if performed after
blood transfusions for concomitant anaemia.
Liver biopsy is not usually possible because of
the severe coagulopathy, but buccal mucosal
biopsy,8 urinary cytology and magnetic reso-
nance imaging (MRI) may assist in reaching a
diagnosis. MRI is established as a method
of defining the distribution of iron overload
in haemochromatosis or haemosiderosis in
children and adults. The presence of an
increased amount of the ferric (Fe3+) ion
shortens both T1 and T2 values of the affected
organ, causing a reduction in signal intensity
on the resultant image. T2 weighted
sequences are proving the most sensitive and
have been used in both antenatal and post-
natal periods to investigate potential cases of
neonatal haemochromatosis. A recent report
describes the use ofMRI at 34 weeks of gesta-
tion to diagnose neonatal haemochromatosis.9
Screening of 'at risk' families may be useful if
MRI can give a reliable diagnosis before 24
weeks' gestation and would permit early
antioxidant treatment and iron chelation,
which has successfully been used in three
infants with neonatal haemochromatosis.10
The severity of acute liver failure was not out-
lined and the potential of this treatment
remains unproved. Chelation treatment alone
has been shown to be ineffective in altering the
course of the disease.
Neonatal haemochromatosis is a complex
condition requiring multidisciplinary manage-
ment which includes neonatal intensive care
and exchange transfusion therapy to keep the
child stable while waiting for a suitable graft.
Liver transplantation in neonates poses techni-
cal problems, including the use of reduced
grafts to overcome extreme disparity in size,
mismatch in vessel calibre, and the need for
microsurgical techniques for vascular anasto-
moses. The postoperative care is demanding,
but long term survival and normal develop-
ment are possible.
A better understanding of neonatal
haemochromatosis would lead to a classifi-
cation of the disorder and assist in genetic
counselling of affected families. To date effec-
tive medical treatment is not available and liver
transplantation is presently the treatment of
choice for neonates with acute liver failure as a
result of neonatal haemochromatosis.
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